Cognetivity Neurosciences Ltd
CNSX:CGN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.01
0.01
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
Cognetivity Neurosciences Ltd
CNSX:CGN
|
895.6k CAD |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.1B USD |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
40.1B USD |
Loading...
|
|
| US |
|
Gartner Inc
NYSE:IT
|
17.1B USD |
Loading...
|
|
| IE |
|
ICON PLC
NASDAQ:ICLR
|
14.1B USD |
Loading...
|
|
| US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
12.8B USD |
Loading...
|
|
| US |
|
Charles River Laboratories International Inc
NYSE:CRL
|
10.7B USD |
Loading...
|
|
| US |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
8.2B USD |
Loading...
|
|
| US |
|
Cytokinetics Inc
NASDAQ:CYTK
|
7.9B USD |
Loading...
|
|
| UK |
|
Verona Pharma PLC
NASDAQ:VRNA
|
7.4B USD |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
Cognetivity Neurosciences Ltd
Glance View
Cognetivity Neurosciences Ltd. operates as a technology company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-03-19. The firm is engaged in developing a cognitive testing platform, the integrated cognitive assessment (ICA), for use in medical and commercial environments for allowing early diagnosis of dementia. The Company’s ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of cognitive impairment by testing the performance of brain. Its products include CognICA and OptiMind. The CognICA has various applications from early detection of cognitive impairment in dementia and multiple sclerosis (MS), to long-term health monitoring, corporate wellness, and personalized brain health. The OptiMind is a wellness app that measures individuals everyday cognitive performance. The firm serves various industries, including healthcare, elder care, enterprise, everyday use, and research. The ICA is available for clinical use in the United States of America, United Kingdom and Europe.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Cognetivity Neurosciences Ltd is -4 474%, which is above its 3-year median of -9 482.1%.
Over the last 10 months, Cognetivity Neurosciences Ltd’s Operating Margin has increased from -13 868.7% to -4 474%. During this period, it reached a low of -13 868.7% on Jan 31, 2023 and a high of -4 474% on Dec 1, 2023.